Advertisement

Topics

The National Hemophilia Foundation Company Profile

14:42 EDT 25th September 2018 | BioPortfolio

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.


News Articles [1319 Associated News Articles listed on BioPortfolio]

Five Deaths in Genentech's Hemlibra Patients

The Hemophilia Federation of America and the National Hemophilia Foundation announced that they had been contacted by Genentech, a Roche company, about the deaths of five patients receiving Hemlibra (...

ASH to Collaborate on Clinical Practice Guidelines on Diagnosis and Management of von Willebrand Disease

WASHINGTON, June 21, 2018 /PRNewswire-USNewswire/ — The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemoph...

Leading National Genetics Foundation to Present Adapted Bikes to Charlotte Area Children with ...

The annual ACMG Foundation Day of Caringis sponsored by the ACMG Foundation for Genetic and Genomic Medicine, a prominent national non-profit genetics foundation based Read more...

ASH to collaborate on clinical practice guidelines of von Willebrand Disease

(American Society of Hematology) The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), Wo...

ASH to collaborate on clinical practice guidelines on von Willebrand Disease

(American Society of Hematology) The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), Wo...

Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More

Sometimes disruption comes in waves. Since the 1990s, hemophilia patients have had to inject themselves with drugs a few times a week to prevent dangerous internal bleeding. That could soon change. On...

NSF 'supermagnet' laboratory receives $184 million renewal

(National Science Foundation) The National Science Foundation (NSF) has renewed support for the National High Magnetic Field Laboratory (MagLab) with $184 million over the next five years, a funding i...

uniQure, Bioverativ Unveil Positive Data for Hemophilia B and Hemophilia A Patients

Hemophilia B patients have some good news to cheer. Data suggests that uniQure’s AAV5 gene therapy may be viable treatments for 97 percent of patients. However, uniQure wasn’t the only company tou...

Drugs and Medications [516 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [1243 Associated PubMed Articles listed on BioPortfolio]

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Committee of National Societies Abstracts.

Optimization of prophylaxis for hemophilia A.

Prophylactic injections of factor VIII reduce the incidence of bleeds and slow the development of joint damage in people with hemophilia. The aim of this study was to identify optimal person-specific ...

The burden of musculoskeletal disorders in Mexico at national and state level, 1990-2016: estimates from the global burden of disease study 2016.

Worldwide, musculoskeletal (MSK) disorders are the second cause of living with disability. According to our data, in Mexico, MSK conditions are an important cause of disability, at national and state ...

Comments on Feskanich et al.: Milk and other dairy foods and risk of hip fracture in men and women.

Association between gout and osteoporosis risk in the United Kingdom.

Clinical Trials [1623 Associated Clinical Trials listed on BioPortfolio]

ATHN 7: Hemophilia Natural History Study

This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as...

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

To collect and analyze data on females with hemophilia so as to better define the difference between the study population and the male population with hemophilia.

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

To correlate the HLA type and genetic defect with hemophilia A.

Epidemiology and Immunology of Hemophilia A Inhibitors

To determine the risk factors associated with inhibitor formation in hemophilia A and to study the mechanism of tolerance in the murine hemophilia A model.

Companies [2383 Associated Companies listed on BioPortfolio]

The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education,...

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

Hemophilia Foundation of Michigan

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treat...

Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available ...

More Information about "The National Hemophilia Foundation" on BioPortfolio

We have published hundreds of The National Hemophilia Foundation news stories on BioPortfolio along with dozens of The National Hemophilia Foundation Clinical Trials and PubMed Articles about The National Hemophilia Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The National Hemophilia Foundation Companies in our database. You can also find out about relevant The National Hemophilia Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record